+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Neuropathy Pain Treatment Market 2024-2028 - Product Thumbnail Image

Neuropathy Pain Treatment Market 2024-2028

  • Report
  • November 2023
  • 171 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Gastric Cancer Diagnostic Procedure Market Report 2026 - Product Thumbnail Image

Gastric Cancer Diagnostic Procedure Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Rare Disease Diagnostics Market Report 2026 - Product Thumbnail Image

Rare Disease Diagnostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Dental Regeneration Market 2024-2028 - Product Thumbnail Image

Dental Regeneration Market 2024-2028

  • Report
  • December 2023
  • 148 Pages
  • Global
From
From
Loading Indicator